The second-generation ‘atypical’ antipsychotics: similar improved efficacy but different neuroendocrine side effects
- 31 January 2003
- journal article
- review article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 28, 1-7
- https://doi.org/10.1016/s0306-4530(02)00109-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Schizophrenia: Reproductive Hormones and the BrainAmerican Journal of Psychiatry, 2002
- Estrogen — a potential treatment for schizophreniaSchizophrenia Research, 2001
- The Corticosteroid Receptor Hypothesis of DepressionNeuropsychopharmacology, 2000
- The hypothalamic–pituitary–thyroid axis in patients with schizophreniaSchizophrenia Research, 2000
- The Cholinergic System in Schizophrenia Reconsidered: Anticholinergic Modulation of Sleep and Symptom ProfilesNeuropsychopharmacology, 1999
- Biological predictors of 1-year outcome in schizophrenia in males and femalesSchizophrenia Research, 1996
- Schizophrenia throughout life: sex differences in severity and profile of symptomsSchizophrenia Research, 1996
- Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenicsPsychoneuroendocrinology, 1992
- A prospective study of postpartum psychoses in a high‐risk group: I. Clinical characteristics of the current postpartum episodesActa Psychiatrica Scandinavica, 1986
- Dexamethasone Suppression Test in Depression and other Psychiatric IllnessThe British Journal of Psychiatry, 1983